| P2093 | author name string | H Wu | |
| | H Sun | |
| | H Zhang | |
| | L M Tsvetkov | |
| | N Gavrilova | |
| | R Mamillapalli | |
| | V T Mihaylova | |
| P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
| | The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 |
| | CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 |
| | p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27 | Q28137813 |
| | SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 | Q28137860 |
| | PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway | Q28588309 |
| | New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Q29616144 |
| | PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells | Q33586807 |
| | Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27 | Q33887383 |
| | p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells | Q40918524 |
| | Cyclin E-CDK2 is a regulator of p27Kip1. | Q42800258 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 263-267 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Current Biology | Q1144851 |
| P1476 | title | PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2) | |
| P478 | volume | 11 | |